معرفی
Elīna Aleksejeva is a Lecturer in the Department of Paediatrics at Rīga Stradiņš University (RSU). Her academic work focuses on pediatric respiratory medicine, autoimmune disorders, and infectious diseases, particularly cystic fibrosis and the impacts of COVID-19. She contributes to global research initiatives, including the European Cystic Fibrosis Society's newborn screening program evaluations and studies on pediatric vasculitis cases. Dr. Aleksejeva is a core member of two major research projects: one analyzing clinical and immunogenetic paradigms of COVID-19 (2020–2021) and another improving RSU's educational processes (2018–2023). Her research integrates clinical practice with public health policy, emphasizing early disease detection and therapeutic innovation. She actively participates in international conferences and peer-review activities, maintaining roles in professional societies like the Latvian Paediatric Pulmonology and Allergology Society.
Education & Affiliations:
- Rīga Stradiņš University (Primary affiliation)
Research Interests:
Her work spans cystic fibrosis management, pediatric autoimmune vasculitis (e.g., eosinophilic granulomatosis with polyangiitis), and the impact of respiratory infections on pediatric populations. She explores innovative therapies like mepolizumab for rare pediatric conditions and evaluates newborn screening efficacy for genetic disorders such as CF. Her recent focus includes analyzing post-COVID-19 outcomes in CF patients and dust mite allergen sensitization patterns in Latvia.
Collaborations & Projects:
- Lead expert in the Clinical, biochemical, immunogenetic paradigms of Covid-19 project (2020–2021)
- Contributor to RSU's educational process improvement initiative (2018–2023)
- Global CF Registry Collaboration for cohort studies
Grants & Awards: No specific awards listed, but her projects received funding from the Latvian Council of Science and EU Structural Funds.
Labs & Teams: Engaged with multidisciplinary teams in RSU's Department of Paediatrics and collaborative networks in cystic fibrosis and autoimmune disease research.
